THE RON RECEPTOR TYROSINE KINASE POSITIVELY REGULATES ANGIOGENIC CHEMOKINE PRODUCTION IN PROSTATE CANCER CELLS

por Thobe, Megan N., Gurusamy, Devikala, Pathrose, Peterson, Waltz, Susan E.
Publicado 2009

Hepatocyte growth factor-like protein is required for prostate tumor growth in the TRAMP mouse model

por Vasiliauskas, Juozas, Nashu, Madison A., Pathrose, Peterson, Starnes, Sandra L., Waltz, Susan E.
Publicado 2014

Does Molecular Profiling of KRAS-Mutant Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Help in Treatment Strategy Planning?

por Karim, Nagla Abdel, Ullah, Asad, Pathrose, Peterson, Fathallah, Hassana, Perry, Ashley, Morris, John C., Wang, Jiang, Starnes, Sandra L.
Publicado 2022

The Use of Pharmacogenomics for Selection of Therapy in Non-Small-Cell Lung Cancer

por Karim, Nagla A, Bui, Hai, Pathrose, Peterson, Starnes, Sandra, Patil, Ninad, Shehata, Mahmoud, Mostafa, Ahmed, Rao, MB, Zarzour, Ahmad, Anderson, Marshall
Publicado 2014

THE RON RECEPTOR PROMOTES PROSTATE TUMOR GROWTH IN THE TRAMP MOUSE MODEL

por Thobe, Megan N., Gray, Jerilyn K., Gurusamy, Devikala, Paluch, Andrew M., Wagh, Purnima K., Pathrose, Peterson, Lentsch, Alex B., Waltz, Susan E.
Publicado 2011

HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses

por Benight, Nancy M., Wagh, Purnima K., Zinser, Glendon M., Peace, Belinda E., Stuart, William D., Vasiliauskas, Juozas, Pathrose, Peterson, Starnes, Sandra L., Waltz, Susan E.
Publicado 2015